cbdMD (YCBD) Research & Development : $0.05 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is cbdMD Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. cbdMD's Research & Development for the three months ended in Mar. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0.05 Mil.

cbdMD Research & Development Historical Data

The historical data trend for cbdMD's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

cbdMD Research & Development Chart

cbdMD Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Research & Development

Get a 7-Day Free Trial

0.42

1.42

0.63

0.17

cbdMD Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															0.06	0.03	0.02	0.01	-

cbdMD Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.

cbdMD (AMEX:YCBD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

cbdMD Research & Development Related Terms

Thank you for viewing the detailed overview of cbdMD's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

cbdMD (YCBD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBD) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

YCBDPA.PFD:USA

Address

8845 Red Oak Boulevard, Charlotte, NC, USA, 28217

Website

https://www.cbdmd.com

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Executives

Thomas Ronan Kennedy	officer: Interim CEO and CFO	8845 RED OAK BLVD, CHARLOTTE NC 28217
Bakari T. Sellers	director	4231 VOORHEES ROAD, DENMARK SC 29042
Raines William F Iii	director	8314 TOSOMOCK LANE, HUNTERSVILLE NC 28078
Scott G. Stephen	director	4249 NORTH WINCHESTER AVE., CHICAGO IL 60613
Sibyl Nichole Swift	director	730 HAWTHORNE LANE, APT 441, CHARLOTTE NC 28204
Kevin Macdermott	officer: President	9580 CALDWELL RD, MOUNT ULLA NC 28125
Wiesehan John J Iii	officer: Chief Revenue Officer	8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Sim Farar	director	8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Martin A. Sumichrast	director, officer: Chairman of the Board and CEO	11125 COLONIAL COUNTRY LANE, CHARLOTTE NC 28277
Raymond Scott Coffman	director	230 S. TRYON ST., #1302, CHARLOTTE NC 28202
Peter J. Ghiloni	director	115 DEER ESTATES LANE, PONTE VEDRA BEACH FL 32082
Mark S Elliott	officer: CFO & COO	C/O LEVEL BRANDS, INC., 4521 SHARON ROAD, SUITE 450, CHARLOTTE NC 28211
Gregory C Morris	director	421 CRANBORNE CHASE, FORT MILL SC 29708
Caryn Nicole Dunayer	officer: President	8476 CATAWBA DOVE DR., BELMONT NC 28012
Erik Sterling	10 percent owner	5505 KALANIANAOLE HWY, HONOLULU HI 96821